United States · FDA National Drug Code directory
Rasagiline mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71921-408_3b57a1c9-0ad9-40cf-a972-29851a658489
- Product NDC
- 71921-408
- Form
- TABLET
- Composition / generic term
- Rasagiline mesylate
- Labeler
- Florida Pharmaceutical Products, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260414
- Source listing expiry
- 20271231
Source-listed ingredients
- RASAGILINE MESYLATE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71921-408-33) · 71921-408-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →